https://www.biocopy.com/redefining-tcrm-safety-with-validate/2026-10-02T00:23:01+02:00https://www.biocopy.com/biocopy-expands-corporate-portfolio-with-acquisition-of-perspix-biotech-gmbh/2026-09-30T23:32:38+02:00https://www.biocopy.com/biocopy-chooses-genedata-for-ai-powered-multi-specific-antibody-discovery/2026-09-30T23:55:07+02:00https://www.biocopy.com/wirtschaftswoche-magazine-ranks-matthias-wiedenfels-among-germanys-biotech-pioneers-of-the-coming-decade/2026-10-02T11:41:08+02:00https://www.biocopy.com/epitox-completing-our-validate-platform-for-tcr-mimic-antibody-development/2026-10-02T01:20:57+02:00https://www.biocopy.com/epipredict-ml-powered-identification-of-phla-off-targets-for-tcr-mimic-antibodies/2026-10-02T01:46:25+02:00https://www.biocopy.com/dr-matthias-wiedenfels-discusses-biocopys-breakthrough-ai-powered-approach-on-biobiz-buzz-podcast/2026-10-02T09:56:54+02:00https://www.biocopy.com/biocopy-advances-ai-driven-cancer-therapies-with-strategic-investment-from-haute-capital/2026-10-02T11:37:43+02:00https://www.biocopy.com/an-ultra-high-throughput-screen-for-the-evaluation-of-peptide-hla-binder-interactions/2026-10-02T15:15:15+02:00